# Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications

> **NCT03527160** · — · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 134 (actual)

## Conditions studied

- Acute Kidney Injury
- Nephrotoxicity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03527160
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2021-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03527160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03527160, "Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03527160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*